Lexeo Therapeutics has agreed to acquire Mantle Therapeutics for an upfront payment of $8.3 million. The acquisition aims to expand Lexeo Therapeutics' Friedreich’s ataxia portfolio and secure three strategic collaborations to support its lead asset.
Lexeo Therapeutics Agrees To Acquire Mantle Therapeutics
Lexeo Therapeutics Agrees To Acquire Mantle Therapeutics
AcquisitionUSD8,300,000Professional Services
Get the full Mantle Therapeutics company profile
Access contacts, investors, buying signals & more
Acquired
Mantle Therapeutics
Professional Services
Deal value
USD8,300,000
September 22, 2026
Acquirer
Lexeo Therapeutics
Biotechnology Research
Unlock GTM signals
Discover Mantle Therapeutics's tech stack and active buying intent.
Unlock key decision-makers
Get direct access to the decision-makers at Mantle Therapeutics.